Actively Recruiting
Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children MYOPSTOP
Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2025-03-18
50
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Myopia, especially among children and adolescents, is increasing worldwide and has reached epidemic levels in some Asian regions. Researchers are focusing on evaluating the use of atropine 0.01% eye drops as a treatment for progressive myopia in children. This observational study aims to build a database to share results and clinical experience, particularly within the French population where published data are limited. Participants in this study are children with active myopia who are treated daily with atropine 0.01% eye drops. The study involves collecting detailed ophthalmological and demographic data at regular intervals. These include measurements such as refractions, intra-ocular pressure, dilated eye exams, and biometry, all assessed every six months until participants reach 18 years of age. Throughout the study, participants will undergo comprehensive eye examinations and monitoring every six months to track changes and potential side effects like halos or photophobia. Researchers will gather data on treatment adherence and any undesirable events. The study spans from the initial treatment phase through to age 18, providing long-term observation of the treatment's impact and safety.
CONDITIONS
Brief Title
Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children with active myopia treated with ATROPINE 0.01% eye drops
- Patient affiliated with a social security organization
- Agreement of both parents
You will not qualify if you...
- Non compliance with treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Every 6 months up to age 18 years
Participants are observed over time with regular eye examinations and data collection related to their myopia treatment and eye health.
Visits every 6 months
Trial Site Locations
Total: 1 location
1
CHU de Saint Etienne
Saint-Etienne, France, 42055
Actively Recruiting
Research Team
M
Marie Caroline TRONE
M
Marie PEURIERE
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here